Increased levels of carbonic anhydrase II in the developing Down syndrome brain

Brain Research

Volumn 1190, Issue 1, 2008, Pages 193-205

  Palminiello, Sonia ^b   Kida, Elizabeth ^a   Kaur, Kulbir ^a   Walus, Marius ^a   Wisniewski, Krystyna E ^a,c   Wierzba Bobrowicz, Teresa ^d   Rabe, Ausma ^a   Albertini, Giorgio ^b   Golabek, Adam A ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Brain development; Carbonic anhydrase II; Down syndrome; Myelin basic protein; Proteomic; Ts65Dn mouse

Indexed keywords

CARBONATE DEHYDRATASE II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; BRAIN DEVELOPMENT; CELLULAR DISTRIBUTION; CEREBELLUM; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN SYNDROME; ELECTROLYTE BALANCE; ENZYME LOCALIZATION; FEMALE; FETUS; FLUID BALANCE; FRONTAL CORTEX; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PH; PRIORITY JOURNAL; PROTEOMICS; PUTAMEN; REGULATORY MECHANISM; SEIZURE; UPREGULATION; WHITE MATTER;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ANIMALS; BRAIN; CARBONIC ANHYDRASE II; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; DOWN SYNDROME; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOBLOTTING; MALE; MICE; MICE, MUTANT STRAINS; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; REFERENCE VALUES; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS; TRISOMY;

MUS;

EID: 37549005632     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.11.023     Document Type: Article

References (72)

1. Akeson E.C., Lambert J.P., Narayanswami S., Gardiner K., Bechtel L.J., and Davisson M.T. Ts65Dn - localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome. Cytogenet. Cell Genet. 93 (2001) 270-276
2. Banik N.L., Davison A.N., Palo J., and Savolainen H. Biochemical studies on myelin isolated from the brains of patients with Down's syndrome. Brain 98 (1975) 213-218
3. Baxter L.L., Moran T.H., Richtsmeier J.T., Troncoso J., and Reeves R.H. Discovery and genetic localization of Down syndrome cerebellar phenotype using the Ts65Dn mouse. Hum. Mol. Genet. 9 (2000) 195-202
4. Belichenko P.V., Masliah E., Kleschevnikov A.M., Villar A.J., Epstein C.J., Salehi A., and Mobley W.C. Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome. J. Comp. Neurol. 480 (2004) 281-298
5. Brody B.A., Kinney H.C., Kloman A.S., and Gilles F.H. Sequence of central nervous system myelination in human infancy. I. An autopsy study of myelination. J. Neuropathol. Exp. Neurol. 46 (1987) 283-301
6. Cerghet M., Skoff R.P., Bessert D., Zhang Z., Mullins C., and Ghandour M.S. Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents. J. Neurosci. 26 (2006) 1439-1447
7. Chrast R., Scott H.S., Papasavvas M.P., Rossier C., Antonarakis E.S., Barras C., Davisson M.T., Schmidt C., Estivill X., Dierssen M., Pritchard M., and Antonarakis S.E. The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. Genome Res. 10 (2000) 2006-2021
8. Counillon L., and Pouysségur J. The expanding family of eucaryotic Na(+)/H(+) exchangers. J. Biol. Chem. 275 (2000) 1-4
9. Cumming W.A., and Ohlsson A. Intracranial calcification in children with osteopetrosis caused by carbonic anhydrase II deficiency. Radiology 157 (1985) 325-327
10. Davisson M.T., Schmidt C., and Akeson E.C. Segmental trisomy for murine chromosome 16: a new system for studying Down syndrome. In: Patterson D., and Epstein C.J. (Eds). Molecular Genetics of Chromosome 21 and Down Syndrome (1990), Wiley-Liss, New York 263-280
11. DeLuca G.C., Nagy Z., Esiri M.M., and Davey P. Evidence for a role for apoptosis in central pontine myelinolysis. Acta Neuropathol. (Berl.) 103 (2002) 590-598
12. Demas G.E., Nelson R.J., Krueger B.K., and Yarowsky P.J. Impaired spatial working and reference memory in segmental trisomy (Ts65Dn) mice. Behav. Brain Res. 90 (1998) 199-201
13. Dyer C.A. The structure and function of myelin: from inert membrane to perfusion pump. Neurochem. Res. 27 (2002) 1279-1292
14. Engidawork E., and Lubec G. Molecular changes in fetal Down syndrome brain. J. Neurochem. 84 (2003) 895-904
15. Epstein C.J. Down syndrome. In: Scriver C.R. (Ed). The Metabolic and Molecular Bases of Inherited Disease (1995), McGraw-Hill, New York 749-794
16. Escorihuela R.M., Fernandez-Teruel A., Vallina I.F., Baamonde C., Lumbreras M.A., Dierssen M., Tobena A., and Florez J. A behavioral assessment of Ts65Dn mice: a putative Down syndrome model. Neurosci. Lett. 199 (1995) 143-146
17. Fernandez F., Morishita W., Zuniga E., Nguyen J., Blank M., Malenka R.C., and Garner C.C. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat. Neurosci. 10 (2007) 411-413
18. FitzPatrick D.R., Ramsay J., McGill N.I., Shade M., Carothers A.D., and Hastie N.D. Transcriptome analysis of human autosomal trisomy. Hum. Mol. Genet. 11 (2002) 3249-3256
19. Gardiner K., Fortna A., Bechtel L., and Davisson M.T. Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene 318 (2003) 137-147
20. Ghandour M.S., Langley O.K., Vincendon G., Gombos G., Filippi D., Limozin N., Dalmasso D., and Laurent G. Immunochemical and immunohistochemical study of carbonic anhydrase II in adult rat cerebellum: a marker for oligodendrocytes. Neuroscience 5 (1980) 559-571
21. Ghandour M.S., Langley O.K., Zhu X.L., Waheed A., and Sly W.S. Carbonic anhydrase IV on brain capillary endothelial cells: marker associated with the blood-brain barrier. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 6823-6827
22. Golabek A.A., Kida E., Walus M., Wujek P., Mehta P., and Wisniewski K.E. Biosynthesis, glycosylation, and enzymatic processing in vivo of human tripeptidyl-peptidase I. J. Biol. Chem. 278 (2003) 7135-7145
23. Halmi P., Parkkila S., and Honkaniemi J. Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus. Neurochem. Int. 48 (2006) 24-30
24. Holtzman D.M., Santucci D., Kilbridge J., Chua-Couzens J., Fontana D.J., Daniels S.E., Johnson R.M., Chen K., Sun Y., Carlson E., Alleva E., Epstein C.J., and Mobley W.C. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 13333-13338
25. Hook E.B. Unbalanced Robertsonian translocations associated with Down's syndrome or Patau's syndrome: chromosome subtype, proportion inherited, mutation rates, and sex ratio. Hum. Genet. 59 (1981) 235-239
26. Insausti A.M., Megias M., Crespo D., Cruz-Orive L.M., Dierssen M., Vallina I.F., Insausti R., and Florez J. Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of Down syndrome. Neurosci. Lett. 253 (1998) 175-178
27. Johannsen P., Christensen J.E., Goldstein H., Nielsen V.K., and Mai J. Epilepsy in Down syndrome-prevalence in three age groups. Seizure 5 (1996) 121-125
28. Kida E., Palminiello S., Golabek A.A., Walus M., Wierzba-Bobrowicz T., Rabe A., Albertini G., and Wisniewski K.E. Carbonic anhydrase II in the developing and adult human brain. J. Neuropathol. Exp. Neurol. 65 (2006) 664-674
29. Kinney H.C., Brody B.A., Kloman A.S., and Gilles F.H. Sequence of central nervous system myelination in human infancy. II. Patterns of myelination in autopsied infants. J. Neuropathol. Exp. Neurol. 47 (1988) 217-234
30. Kleschevnikov A.M., Belichenko P.V., Villar A.J., Epstein C.J., Malenka R.C., and Mobley W.C. Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J. Neurosci. 24 (2004) 8153-8160
31. Kumpulainen T., and Nyström S.H. Immunohistochemical localization of carbonic anhydrase isoenzyme C in human brain. Brain Res. 220 (1981) 220-225
32. Kumpulainen T., Dahl D., Korhonen L.K., and Nystrom S.H. Immunolabeling of carbonic anhydrase isoenzyme C and glial fibrillary acidic protein in paraffin-embedded tissue sections of human brain and retina. J. Histochem. Cytochem. 31 (1983) 879-886
33. Kurt M.A., Davies D.C., Kidd M., Dierssen M., and Florez J. Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice. Brain Res. 858 (2000) 191-197
34. Kurt M.A., Kafa M.I., Dierssen M., and Davies D.C. Deficits of neuronal density in CA1 and synaptic density in the dentate gyrus, CA3 and CA1, in a mouse model of Down syndrome. Brain Res. 1022 (2004) 101-109
35. Lappe-Siefke C., Goebbels S., Gravel M., Nicksch E., Lee J., Braun P.E., Griffiths I.R., and Nave K.A. Disruption of Cnpl uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 33 (2003) 366-374
36. Lewis S.E., Erickson R.P., Barnett L.B., Venta P.J., and Tashian R.E. N-ethyl-N-nitrosourea-induced null mutation at the mouse Car-2 locus: an animal model for human carbonic anhydrase II deficiency syndrome. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 1962-1966
37. Li X., Alvarez B., Casey J.R., Reithmeier R.A., and Fliegel L. Carbonic anhydrase II binds to and enhances activity of the Na+/H+ exchanger. J. Biol. Chem. 277 (2002) 36085-36091
38. Ligon K.L., Fancy S.P.J., Franklin R.J.M., and Rowitch D.H. Olig gene function in CNS development and disease. Glia 54 (2006) 1-10
39. Liu D.P., Schmidt C., Billings T., and Davisson M.T. Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome. Biotechniques 35 (2003) 1170-1174
40. Lorenzi H.A., and Reeves R.H. Hippocampal hypocellularity in the Ts65Dn mouse originates early in development. Brain Res. 1104 (2006) 153-159
41. Mao R., Wang X., Spitznagel Jr. E.L., Frelin L.P., Ting J.C., Ding H., Kim J.W., Ruczinski I., Downey T.J., and Pevsner J. Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart. Genome Biol. 6 (2005) R107
42. Martinez-Cué C., Baamonde C., Lumbreras M.A., Vallina I.F., Dierssen M., and Florez J. A murine model for Down syndrome shows reduced responsiveness to pain. NeuroReport 10 (1999) 1119-1122
43. Martinez-Cué C., Rueda N., Garcia E., and Florez J. Anxiety and panic responses to a predator in male and female Ts65Dn mice, a model for Down syndrome. Genes Brain Behav. 5 (2006) 413-422
44. Mathis C., Denisenko-Nehrbass N., Girault J.A., and Borrelli E. Essential role of oligodendrocytes in the formation and maintenance of central nervous system nodal regions. Development 128 (2001) 4881-4890
45. McMurtrie H.L., Cleary H.J., Alvarez B.V., Loiselle F.B., Sterling D., Morgan P.E., Johnson D.E., and Casey J.R. The bicarbonate transport metabolon. J. Enzyme Inhib. Med. Chem. 19 (2004) 231-236
46. Morris C.S., Esiri M.M., Sprinkle T.J., and Gregson N. Oligodendrocyte reactions and cell proliferation markers in human demyelinating diseases. Neuropathol. Appl. Neurobiol. 20 (1994) 272-281
47. Naka S., Minakata M., Tatamiya T., Kimura H., Kumegawa M., Ishida N., and Takeya T. Activation of human CAII gene promoter by v-Src: existence of Ras-dependent and -independent pathways. Biochem. Biophys. Res. Commun. 272 (2000) 808-815
48. O'Farrell P.H. High-resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250 (1975) 4007-4021
49. O'Leary M.T.O., and Blakemore W.F. Use of a rat Y chromosome probe to determine the long-term survival of glial cells transplanted into areas of CNS demyelination. J. Neurocytol. 26 (1997) 191-206
50. Palo J., and Savolainen H. The proteins of human myelin in inborn errors of metabolism and in chromosomal anomalies. Acta Neuropathol. (Berl.) 24 (1973) 56-61
51. Pastorekova S., Parkkila S., Pastorek J., and Supuran C.T. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J. Enzyme Inhib. Med. Chem. 19 (2004) 199-229
52. Pueschel S.M., Louis S., and McKnight P. Seizure disorders in Down syndrome. Arch. Neurol. 48 (1991) 318-320
53. Rasband M.N., Tayler J., Kaga Y., Yang Y., Lappe-Siefke C., Nave K.A., and Bansal R. CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS. Glia 50 (2005) 86-90
54. Reeves R.H., Irving N.G., . Moran T.H., Wohn A., Kitt C., Sisodia S.S., Schmidt C., Bronson R.T., and Davisson M.T. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat. Genet. 11 (1995) 177-184
55. Roper R.J., Baxter L.L., Saran N.G., Klinedinst D.K., Beachy P.A., and Reeves R.H. Defective cerebellar response to mitogenic Hedgehog signaling in Down syndrome mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 1452-1456
56. Saran N.G., Pletcher M.T., Natale J.E., Cheng Y., and Reeves R.H. Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Hum. Mol. Genet. 12 (2003) 2013-2019
57. Shah S.N. Fatty acid composition of lipids of human brain myelin and synaptosomes: changes in phenylketonuria and Down's syndrome. Int. J. Biochem. 10 (1979) 477-482
58. Sly W.S., Hewett-Emmett D., Whyte M.P., Yu Y.S., and Tashian R.E. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 2752-2756
59. Sly W.S., Whyte M.P., Sundaram V., Tashian R.E., Hewett-Emmett D., Guibaud P., Vainsel M., Baluarte H.J., Gruskin A., and Al-Mosawi M. Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N. Engl. J. Med. 313 (1985) 139-145
60. Sly W.S., and Hu P.Y. Human carbonic anhydrases and carbonic anhydrase deficiencies. Ann. Rev. Biochem. 64 (1995) 375-401
61. Spicer S.S., Lewis S.E., Tashian R.E., and Schulte B.A. Mice carrying a CAR-2 null allele lack carbonic anhydrase II immunohistochemically and show vascular calcification. Am. J. Pathol. 34 (1989) 947-954
62. Sterling D., Reithmeier R.A., and Casey J.R. A transport metabolon. Functional interaction of carbonic anhydrase II and chloride/bicarbonate exchangers. J. Biol. Chem. 276 (2001) 47886-47894
63. Sun M.K., and Alkon D.L. Carbonic anhydrase gating of attention: memory therapy and enhancement. Trends Pharmacol. Sci. 23 (2002) 83-89
64. Velisek L., Moshe S.L., Xu S.G., and Cammer W. Reduced susceptibility to seizures in carbonic anhydrase II deficient mutant mice. Epilepsy Res. 14 (1993) 115-121
65. Vercauteren F.G.G., Bergeron J.J.M., Vandesande F., Arckens L., and Quirion R. Proteomic approaches in brain research and neuropharmacology. Eur. J. Pharmacol. 500 (2004) 385-398
66. Vlkolinsky R., Cairns N., Fountoulakis M., and Lubec G. Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer's disease. Neurobiol. Aging 22 (2001) 547-553
67. Thiry A., Dogné J.M., Supuran C.T., and Masereel B. Carbonic anhydrase inhibitors as anticonvulsant agents. Curr. Top. Med. Chem. 7 (2007) 855-864
68. Wegner M., and Stolt C.C. From stem cells to neurons and glia: a Soxist's view of neural development. Trends Neurosci. 28 (2005) 583-588
69. Wisniewski K.E., and Schmidt-Sidor B. Postnatal delay of myelin formation in brains from Down syndrome infants and children. Clin. Neuropathol. 8 (1989) 55-62
70. Wisniewski K.E., French J.H., Rosen J.F., Kozlowski P.B., Tenner M., and Wisniewski H.M. Basal ganglia calcification (BGC) in Down's syndrome (DS) - another manifestation of premature aging. Ann. N.Y. Acad. Sci. 396 (1982) 179-189
71. Wisniewski K.E., Kida E., Golabek A.A., Walus M., Rabe A., Palminiello S., and Albertini G. Down syndrome: from pathology to pathogenesis. In: Rondal J.A., and Perera J. (Eds). Down Syndrome. Neurobehavioural Specificity (2006), John Wiley & Sons, Chichester 17-33
72. Xin M., Yue T., Ma Z., Wu F.-f., Gow A., and Lu Q.R. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J. Neurosci. 25 (2005) 1354-1365